1. Home
  2. BLBD vs NNNN Comparison

BLBD vs NNNN Comparison

Compare BLBD & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

HOLD

Current Price

$49.27

Market Cap

1.7B

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$21.83

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLBD
NNNN
Founded
1927
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
BLBD
NNNN
Price
$49.27
$21.83
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$64.60
N/A
AVG Volume (30 Days)
472.6K
35.9K
Earning Date
02-04-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
22.79
N/A
EPS
3.88
0.06
Revenue
$1,480,099,000.00
$6,920,153.00
Revenue This Year
$4.86
N/A
Revenue Next Year
$3.41
N/A
P/E Ratio
$12.82
$328.91
Revenue Growth
9.87
N/A
52 Week Low
$30.04
$5.18
52 Week High
$61.95
$55.65

Technical Indicators

Market Signals
Indicator
BLBD
NNNN
Relative Strength Index (RSI) 48.13 38.85
Support Level $48.75 $18.50
Resistance Level $50.81 $31.52
Average True Range (ATR) 1.50 4.57
MACD 0.22 -1.76
Stochastic Oscillator 59.02 14.29

Price Performance

Historical Comparison
BLBD
NNNN

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: